Protecting Patient Health

Sanofi applies its own global policies to improve efficiency of operational processes and identify development areas. This approach allows Sanofi units in all countries to use the same terminology and continue to develop at the same level. Such harmony brings success as well. Improving process efficiency is among the key tasks of the Country Quality unit. Regular audits are conducted both internally and externally at customers to measure process efficiency and measurements are made with the generated reports. Furthermore, surveys or round table meetings are conducted at regular intervals to obtain feedback from process owners. In defining quality processes, the Company considers primarily the Ministry of Health regulations, then Sanofi’s global and regional requirements and lastly feedback received from customers or employees about current processes or the results obtained from monitored processes. Global resources or regional regulations are used as reference documents when defining processes. 

Sanofi Turkey's activities aimed to inform healthcare professionals and general public are carried out in an accurate, balanced and scientific manner in compliance with the rules determined by the authorities. The descriptive documents prepared for the customers are approved by the in-house healthcare professionals. These documents are delivered by the field teams, who are trained specifically in this area. The company's Medical Information Unit responds to complaints and questions posed by the stakeholders of Sanofi Turkey. The company's sales representatives share the various results from market research on the importance of in-pharmacy practices with patients. Merchandizing materials for the products falling within the scope of our unit are produced and placed in pharmacies in line with these research results.  

The essential point about imparting product and service information is that the employees responsible for sales have complete information on and are equipped about the products and processes. Sanofi Turkey organizes webinars or face-to-face meetings on a monthly or bi-monthly basis as needed in order to equip its sales staff with up-to-date medical and marketing information. In these webinars, the Marketing Department provides refreshers on strategies and tactics, shares competition analysis and the latest marketing campaigns, and the Medical Department shares medical outcomes, updates and guidelines discussed in congresses, as well as competition and clinical study information with the field team. Cycle meetings and regional meetings are also used as an opportunity to update the sales staff with the latest information. In addition, medical and marketing training is provided within the first five days after the recruitment of new sales staff through the 'Journey to Excellence Program.' The brand team regularly shares with the sales team strategic messages to be delivered in line with the strategy of each product. Moreover, online informative meetings about scientific studies are organized for the entire field team in cooperation with the Medical Department.    

Moreover, we collaborate with the Altı Nokta Association for the Blind, which validates the Braille alphabet used in the packaging of all of Sanofi Turkey's products in the market, to ensure that all individuals in our society receive accurate information about the content of our products. In this context, we have completed the Braille alphabet validation process, which requires experts’ approval of the appropriateness of the Braille alphabet to be used on the outer packaging of all our products in the portfolio, in accordance with the “Regulation on the packaging information, instructions for use and monitoring of medicinal products for human use," and "Guidelines for packaging information and instructions for use of medicinal products for human use,” “Guidelines on the legibility of the packaging information and instructions for use of medicinal products for human use,” and “Guidelines on the inactive ingredients in the packaging information and instructions for use of medicinal products for human use” published by the Ministry of Health TITCK. 

Market Access  
During the year, dialogues with target audiences on all kinds of issues are established through Advisory Board meetings including one-on-one consultations, which offer a platform of communication with doctors in particular. Advisory Board meetings are held for the products to be launched or re-launched during the year. Two Advisory Board meetings have been held in the past year, with the participation of pediatricians, Ear-Nose-Throat (ENT) specialists and gastroenterologists. The strategic outcomes of the meetings were shared with all internal and external stakeholders, with all of the work conducted in accordance with the Sanofi Advisory Board rules and rules pertaining to the organization of scientific meetings. These activities are carried out with the approval of the Ministry of Health in line with the procedures on promotional activities. 

We communicate with physicians and pharmacists through the year via scientific dialogue platforms. These include national and international congresses, product promotion meetings and live broadcasts, where scientific data is approved by the Ministry of Health, are shared. During the year various activities are carried out such as online/offline experience sharing among physicians, local meetings, national conventions (booths, symposia, scientific content), face-to-face visits by the field team and digital corporate content platform, whereby targeted marketing messages and scientifically accurate information on Sanofi products are communicated to physicians. At the end of the activities they attend, physicians are asked to fill out a training assessment questionnaire, which ensures a better quality of content for the subsequent trainings. Our efforts aiming at pharmacists include face-to-face communication with approximately 5,000 pharmacists during pharmaceutical fairs held by wholesalers in the first three months of each year. Risk management is carried out through the close monitoring of all of Sanofi's direct sales customers.